TeamDrive
RUS
Maxim Chernin

Maxim Chernin

Partner

Телефоны:

+7 495 545-39-12

Send message

Maxim has joined to the "Team Drive" in October 2017.

Before that, he headed the Client’s Welfare Department of Sberbank as a Managing director. He was a board member of subsidiaries and played a key part in developing insurance, pension and investment activity of this biggest Russian bank. In 2010 as a CEO Maxim organized from scratch “Sberbank life insurance” project. Today it is recognized market leader in its field. Maxim’s professional record includes 10 years experience in insurer company Allianz (former ROSNO). He started as a specialist of marketing research department and in few years he became a member of the Management Board with a wide range of responsibilities. Companies and departments had been growing strongly under his guidance. His management was cost-effective, profitable for shareholders and provided high-quality services for the clients.

Now Maxim is a member of the Government Expert Council of the Russian Federation and of the Public Council under the Ministry of Health of the Russian Federation.

Since 2010 Maxim leads the committee of life insurance in the All-Russian Insurance Association (ARIA). He is also a member of the Board of the All-Russian Insurance Association and of the Association of Life Insurers. In addition, Maxim is a Board member of PJSC Rosgosstrakh insurance company.

In 2017, Maxim was awarded by the National Financial Award “Reputation” in the nomination “For Personal Merits in the Development of Insurance in Russia”. In 2016 he was included into the “Top 250 of the Russian principals” rating according to the estimation of “Kommersant” magazine. In 2014, Maxim was awarded the ARIA honorary medal "For Merits in the Development of Insurance in Russia". In 2011, the “Finance” magazine included Maxim in the annual list of the most successful young businessperson in Russia.

Maxim graduated with honours from the National Research University “Higher School of Economics” majoring in “Strategic Management”.

Media Center

  • 24 May 2018

    State Duma adopted a bill to simplify registration of drugs

    It will be possible to register drugs that have the same international nonproprietary names, but different trade names, and being manufactured at the same site. The corresponding government bill No. 327290-7 on amendments to the Federal Law “On Circulation of Medicines” was adopted by the State Duma in the third reading.

  • 23 May 2018

    Today’s realities in the development of local and contract manufacturing

    The representatives of pharmaceutical companies met at the forum of the Adam Smith Institute where they shared their views on the development of local and contract manufacturing. Victor Dmitriev, General Director of the Association of Russian Pharmaceutical Manufacturers, said that Russian manufacturers continue to consider the quality of their products as the most important issue.

  • 23 May 2018

    Russian Ministry included the Kirov region biotech cluster in its register

    The Ministry of Industry and Trade of Russia confirmed that the industrial biotechnology cluster of the Kirov region and its specialized organization “The Association of Industrial Biotechnology Cluster” comply with the requirements approved by the Decree of the Russian Government No. 779, dated July 31, 2016.

  • 22 May 2018

    Russian pharmaceutical market: stability in unstable environment

    According to DSM Group, in 2017, the Russian market was worth 1629 billion rubles, which 8% higher than in 2016. For the first time in three years, the market grew in dollar- and euro-denominated terms. In physical terms, the market growth is similar to the dynamics in value terms. Therefore, the factor of higher prices played virtually no role in expanding the market volume. In 2017, the main driver was the increase in the actual consumption of medicinal products, i.e., the growth in terms of sold packages.

Read more